QC
GH icon

Quadrature Capital’s Guardant Health GH Stock Holding History

Quadrature Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,504
Closed -$1.69M – 1569
2025
Q4 		$1.69M Buy
+16,504
New +$1.48M 0.02% 394
2025
Q2 		– Sell
-40,025
Closed -$1.7M – 1205
2025
Q1 		$1.7M Buy
+40,025
New +$1.73M 0.04% 324
2022
Q3 		– Sell
-31,621
Closed -$1.28M – 934
2022
Q2 		$1.28M Buy
+31,621
New +$1.57M 0.05% 268
2022
Q1 		– Sell
-8,713
Closed -$872K – 812
2021
Q4 		$872K Sell
8,713
-3,255
-27% -$337K 0.05% 256
2021
Q3 		$1.5M Buy
+11,968
New +$1.42M 0.05% 201
2021
Q1 		– Sell
-4,133
Closed -$533K – 977
2020
Q4 		$533K Buy
+4,133
New +$476K 0.03% 469
2019
Q4 		– Sell
-14,020
Closed -$895K – 577
2019
Q3 		$895K Sell
14,020
-7,906
-36% -$696K 0.04% 301
2019
Q2 		$1.89M Buy
+21,926
New +$1.67M 0.12% 155

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quadrature Capital's GH Position: Q1 2026 in Review

Quadrature Capital sold out of Guardant Health (GH) in Q1 2026, closing a stake of 16,504 shares — an estimated $1.69M sold.

Quadrature Capital first reported a position in GH in Q2 2019 and held it in 8 quarters. The position peaked at $1.89M in Q2 2019. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Quadrature Capital reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 16,504 Guardant Health shares in Q1 2026, an estimated $1.69M.
  • Quadrature Capital first reported a position in Guardant Health in Q2 2019 and held it in 8 quarters.
  • Quadrature Capital's Guardant Health position peaked at $1.89M in Q2 2019.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.